Bonella et al. indicated that IPF patients who were heterozygous or homozygous carriers of the minor allele of TOLLIP rs5743890 had poor outcomes with approximately 20 months’ median overall survival reduction. Here, TOLLIP is linked to idiopathic pulmonary fibrosis.